Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Br J Psychiatry
1 Clin Neuropharmacol
2 J Clin Psychopharmacol
3 Mol Psychiatry
2 Neuropsychopharmacology
1 Pharmacopsychiatry
8 Psychiatry Res
7 Schizophr Res
1 Trends Neurosci

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Br J Psychiatry

  1. WATSON AJ, Harrison L, Preti A, Wykes T, et al
    Cognitive trajectories following onset of psychosis: a meta-analysis - CORRIGENDUM.
    Br J Psychiatry. 2022 Nov 14:1. doi: 10.1192/bjp.2022.

    Clin Neuropharmacol

  2. NAKAMURA M, Nagamine T
    Clozapine-Induced Fever and Plasma Cytokine Changes in a Patient With Schizophrenia.
    Clin Neuropharmacol. 2022;45:179-183.
    PubMed         Abstract available

    J Clin Psychopharmacol

  3. KIM K, Kim YS, Joo EJ, Kim EJ, et al
    Clozapine Blood Concentration Predicts Corrected QT-Interval Prolongation in Patients With Psychoses.
    J Clin Psychopharmacol. 2022;42:536-543.
    PubMed         Abstract available

  4. CONTRUCCI RR, Heikens M, Beex-Oosterhuis MM
    Case Report: Blepharospasms After the Use of Long-Acting Paliperidone Injections.
    J Clin Psychopharmacol. 2022;42:608-609.

    Mol Psychiatry

  5. WEN J, Trost B, Engchuan W, Halvorsen M, et al
    Rare tandem repeat expansions associate with genes involved in synaptic and neuronal signaling functions in schizophrenia.
    Mol Psychiatry. 2022 Nov 16. pii: 10.1038/s41380-022-01857.
    PubMed         Abstract available

  6. ENE HM, Karry R, Farfara D, Ben-Shachar D, et al
    Mitochondria play an essential role in the trajectory of adolescent neurodevelopment and behavior in adulthood: evidence from a schizophrenia rat model.
    Mol Psychiatry. 2022 Nov 15. pii: 10.1038/s41380-022-01865.
    PubMed         Abstract available

  7. GOO BS, Mun DJ, Kim S, Nhung TTM, et al
    Schizophrenia-associated Mitotic Arrest Deficient-1 (MAD1) regulates the polarity of migrating neurons in the developing neocortex.
    Mol Psychiatry. 2022 Nov 10. pii: 10.1038/s41380-022-01856.
    PubMed         Abstract available


  8. MOYA NA, Yun S, Fleps SW, Martin MM, et al
    The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia.
    Neuropsychopharmacology. 2022 Nov 15. pii: 10.1038/s41386-022-01492.
    PubMed         Abstract available

  9. FENG N, Palaniyappan L, Robbins TW, Cao L, et al
    Working memory processing deficit associated with a nonlinear response pattern of the anterior cingulate cortex in first-episode and drug-naive schizophrenia.
    Neuropsychopharmacology. 2022 Nov 14. pii: 10.1038/s41386-022-01499.
    PubMed         Abstract available


  10. AGUGLIA A, Fusar-Poli L, Natale A, Amerio A, et al
    Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study.
    Pharmacopsychiatry. 2022;55:281-289.
    PubMed         Abstract available

    Psychiatry Res

  11. RIHAL V, Khan H, Kaur A, Singh TG, et al
    Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders.
    Psychiatry Res. 2022;317:114782.
    PubMed         Abstract available

  12. LANGLOIS T, Sanchez-Rodriguez R, Bourcier A, Lamy P, et al
    "Accept voices(c)" group intervention for the management of auditory verbal hallucinations-results at 6 and 12 months.
    Psychiatry Res. 2022;317:114860.
    PubMed         Abstract available

  13. KIM WS, Heo DW, Shen J, Tsogt U, et al
    Altered functional connectivity in psychotic disorder not otherwise specified.
    Psychiatry Res. 2022;317:114871.
    PubMed         Abstract available

  14. LU W, Srijeyanthan J, Mueser KT, Yanos PT, et al
    Predictors of undocumented PTSD in persons using public mental health services.
    Psychiatry Res. 2022;317:114892.
    PubMed         Abstract available

  15. ZHANG Q, Huo JH, Guo L, Wang L, et al
    Common and rare variants within SP4 exert distinct molecular mechanisms contributing to the risk of schizophrenia.
    Psychiatry Res. 2022;318:114948.

    Genetic variation and susceptibility to schizophrenia: Work in progress.
    Psychiatry Res. 2022;318:114949.
    PubMed         Abstract available

  17. RUIZ-DELGADO I, Moreno-Kustner B, Garcia-Medina M, Barrigon ML, et al
    Is Metacognitive Training effective for improving neurocognitive function in patients with a recent onset of psychosis?
    Psychiatry Res. 2022;318:114941.
    PubMed         Abstract available

  18. LV H, Li J, Gao K, Zeng L, et al
    Identification of genetic loci that overlap between schizophrenia and metabolic syndrome.
    Psychiatry Res. 2022;318:114947.
    PubMed         Abstract available

    Schizophr Res

  19. COHEN BM, Singh T, Ongur D, Konstantin GE, et al
    Clinical phenotypes of five patients with psychotic disorders carrying rare schizophrenia-associated loss-of-function variants.
    Schizophr Res. 2022;250:100-103.
    PubMed         Abstract available

  20. NAGENDRA A, Black C, Penn DL
    Black Americans and Schizophrenia: Racism as a Driver of Inequities in Psychosis Diagnosis, Assessment, and Treatment.
    Schizophr Res. 2022 Nov 14. pii: S0920-9964(22)00390.

  21. CONLEY AC, Albert KM, Armstrong K, Johnson JV, et al
    A pilot study of transdermal nicotine effects on facial emotion responding in non-smoking healthy controls and individuals with schizophrenia: Feasibility and effect size estimates.
    Schizophr Res. 2022;250:89-91.

  22. YUAN X, Li X, Kang Y, Pang L, et al
    Gut mycobiota dysbiosis in drug-naive, first-episode schizophrenia.
    Schizophr Res. 2022;250:76-86.
    PubMed         Abstract available

  23. CORRELL CU, Bitter I, Hoti F, Mehtala J, et al
    Factors and their weight in reducing life expectancy in schizophrenia.
    Schizophr Res. 2022;250:67-75.
    PubMed         Abstract available

  24. ZHAI D, Bing J, Shan X, Luo H, et al
    Higher central set point of thyroid homeostasis in drug-naive patients affected by first episode schizophrenia.
    Schizophr Res. 2022;250:62-66.
    PubMed         Abstract available

    A commentary on the interpretability of computational linguistic findings in schizophrenia research.
    Schizophr Res. 2022;250:60-61.

    Trends Neurosci

  26. HALFF EF, Rutigliano G, Garcia-Hidalgo A, Howes OD, et al
    Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders.
    Trends Neurosci. 2022 Nov 8. pii: S0166-2236(22)00211.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.